Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Dose-Dependent Reactions
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug Toxicity: Risk factors
Drug Toxicity: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 6, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Kl de Wit1, Be White, D Goldsmith
1Academic FY2 in the Department of Medicine, Guys and St Thomas NHS Foundation Trust, London.
Thiopurines, developed in 1953, are crucial immunosuppressant and antineoplastic drugs. They are vital for treating leukemia and preventing organ transplant rejection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: